Aspirus Medical Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.00 M
as on 15-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -36.34%
(FY 2021)
- Profit -943.83%
(FY 2021)
- Ebitda -623.65%
(FY 2021)
- Net Worth -223.63%
(FY 2021)
- Total Assets -55.51%
(FY 2021)
About Aspirus Medical Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Aruna Srivastava and Arunansh Srivastava serve as directors at the Company.
- CIN/LLPIN
U74990JH2018PTC011991
- Company No.
011991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aspirus Medical Services Private Limited offer?
Aspirus Medical Services Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Doppler Machine, Medical Imaging Machine & Accessories, Surgical & ICU Equipments, Oxygen Concentrator, Pulse Oximeter, Glucometer & POCT Devices, Ultrasound Machines, ECG Machine.
Who are the key members and board of directors at Aspirus Medical Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Srivastava  | Director | 08-Oct-2018 | Current |
| Arunansh Srivastava | Director | 08-Oct-2018 | Current |
Financial Performance of Aspirus Medical Services.
Aspirus Medical Services Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 36.34% decrease. The company also saw a substantial fall in profitability, with a 943.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 223.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspirus Medical Services?
In 2021, Aspirus Medical Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aspirus Medical Services?
Unlock and access historical data on people associated with Aspirus Medical Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspirus Medical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspirus Medical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
